| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,917.95
|
|
Change (%)
|
17.05 (0.90%)
|
|
Best Buy (RS)
|
1917.5(x36)
|
|
Best Sell (RS)
|
1918.35(x11)
|
|
Today's Range (RS)
|
1,892.45
-
1,922.60
|
|
52-Week Range (RS)
|
1,547.25
-
2,047.55
|
|
Beta (1 Year)
|
0.46
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX |
| News |
|
Corporate Details |
| Sun Pharma update on Lipitor antitrust litigation in US court |
| Sun Pharma receives favorable court ruling in Lipitor patent settlement case in US |
| Sun Pharmaceutical Industries receives ratings action from CRISIL |
| Sun Pharmaceutical Industries consolidated net profit rises 27.04% in the June 2026 quarter |
| Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives growth |
| Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight sessions |
| Sun Pharma receives Organon shareholders approval for merger |
| Sun Pharma receives approval to market semaglutide injection in South Africa |
| Sun Pharma gets nod for Semaglutide injection in South Africa |
| Barometers trade higher; private bank shares jump |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
14-Aug-2026 |
1924.90 |
-1.25 |
| 1Month |
21-Jul-2026 |
1962.15 |
-3.12 |
| 3Month |
21-May-2026 |
1891.15 |
0.52 |
| 6Month |
23-Feb-2026 |
1732.20 |
9.74 |
| 1Year |
21-Aug-2025 |
1639.70 |
15.93 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.88 |
4066.76 |
| SBI BSE SENSEX ETF |
2.31 |
2843.23 |
| ICICI Pru Value Fund |
4.49 |
2740.90 |
| ICICI Pru Equity & Debt Fund |
3.74 |
1961.25 |
| ICICI Pru Large Cap Fund |
2.23 |
1805.14 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,425.10 |
-0.08 |
1,672.20 |
1,165.55 |
115,216.02 |
| Zydus Lifesciences Ltd |
1,104.25 |
-1.41 |
1,205.65 |
835.85 |
111,720.43 |
| Lupin Ltd |
2,190.00 |
-0.14 |
2,530.00 |
1,881.80 |
100,271.10 |
| Dr Reddys Laboratories Ltd |
1,186.45 |
0.97 |
1,414.40 |
1,080.05 |
98,074.41 |
| Laurus Labs Ltd |
1,803.60 |
-0.61 |
1,870.00 |
822.85 |
98,047.76 |
|
|
|
|